Emerging biotech success story PolyNovo assuaged any market fears that its sales would take a hit from the COVID-19 outbreak, reporting 166 per cent growth in sales for the March quarter.

Sales of its burns and wounds dermal scaffold, known as a biodegradable temporising matrix (BTM), were stronger in the second half of March than the first, despite the company having to use video conferencing tools to reach customers.